in Newswire Published on July 21, 2022

Relaxium Sleep Aid Falsely Advertised with ‘Illusory’ Science, Class Action Alleges [DISCONTINUED]

by Corrado Rizzi

Last Updated on February 7, 2024

Lomedico v. American Behavioral Research Institute LLC

Filed: July 18, 2022 § 7:22-cv-06097

A proposed class action alleges the maker of the Relaxium sleep aid has falsely advertised the product as an “all-natural, clinically proven” supplement.

December 9, 2022 – Relaxium Sleep Supplement Class Action Settled

Case Spotlight

Hair Relaxer Lawsuits Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on February 7, 2024 — 11:42 AM

Corrado Rizzi

Corrado Rizzi is the Senior Managing Editor of

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.